Nevertheless, CSPG4 is a prime tumor target antigen [30], since it plays a role in the metastasizing of melanoma [32], and is expressed on activated pericytes during angiogenesis in tumors and hypoxia [33,34,35], the latter making targeting of tumor vasculature possible. The gene discussed is CSPG4; the disease is melanoma.